Market Tracker

09/19 6:35pm ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

8.30
Data as of Sep 19
 -0.15 / -1.78%
Today’s Change
6.12
Today|||52-Week Range
31.73
-46.21%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close8.45
Today’s open8.31
Day’s range8.28 - 8.58
Volume59,373
Average volume (3 months)66,181
Market cap$84.1M
Dividend yield--
Data as of 3:51pm ET, 09/19/2014

Growth & Valuation

Earnings growth (last year)+1.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book8.25

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp+0.45+3.38%
CNDOCoronado Biosciences...+0.09+4.84%
DPRXDipexium Pharmaceuti...+0.07+0.69%
TLOGTetraLogic Pharmaceu...-0.18-4.58%
Data as of 3:59pm ET, 09/19/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$0.00
Annual profit (last year)-$4.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, --

Forecasts